Navigation Links
Agendia Introduces the SYMPHONY™ Breast Cancer Profile With Paraffin Embedded Tissue
Date:12/6/2011

any that develops and markets genomic-based diagnostic products that improve the quality of life for cancer patients and simplifies complex treatment decisions for their physicians. Agendia's Symphony™ suite of breast cancer products is based on the analysis of hundreds of genes in a patient's breast and provides unprecedented biological insight to address complex treatment decisions. Symphony includes MammaPrint, the first and only FDA-cleared IVDMIA breast cancer recurrence assay, BluePrint­­, a molecular subtyping assay, TargetPrint, an ER/PR/HER2 expression assay, and TheraPrint, a therapy selection assay. Together, these tests help physicians determine a patient's individual risk for metastasis, which patients will benefit from chemo or hormonal therapy, and which patients do not require these treatments and can instead be treated with other less arduous and less costly methods.

In addition to the Symphony suite of breast cancer tests, Agendia has a rich pipeline of genomic products in development based on its world-class quantitative gene expression platform. The company also collaborates with pharmaceutical companies to develop companion diagnostic tests in the area of oncology and is a critical partner in the ISPY-2, MINDACT as well as other trials.

Agendia was founded in 2003 as a spin-off of the Netherlands Cancer Institute and is based in Irvine, California, United States, and Amsterdam, the Netherlands. For more information, please visit www.agendia.com.

For further information, please contact:


Ricochet Public Relations
Todd Aydelotte
Tel: +1 212 679 3300 ext. 111
E-mail: todd@ricochetpr.com


'/>"/>
SOURCE Agendia
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Agendia Appoints New CEO and Supervisory Board Member
2. Agendia Receives €1.27 Million in Funding from the EUs Seventh Framework Programme
3. Agendia Inaugurates New State-of-the-Art Genomics Laboratory in Irvine
4. Agendia to Provide Testimony at Public Meeting on FDA Oversight of Laboratory-Developed Tests
5. Agendia to Play Pivotal Role in ISPY-2 Trial for Breast Cancer
6. FDA Broadens Clearance for Agendias MammaPrint(R)
7. /C O R R E C T I O N -- Agendia B.V./
8. Agendias Breast Cancer Recurrence Test MammaPrint Included in International St. Gallen Expert Consensus Recommendations
9. Agendias Breast Cancer Test MammaPrint(R) Identifies New Subset of Low Risk HER2+ Patients
10. Agendias MammaPrint(R) Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
11. Agendia Supports High Profile CME Symposium and Presents Compelling Data at the 2008 San Antonio Breast Cancer Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... NEW YORK , Aug. 28, 2014 /PRNewswire/ ... report is available in its catalogue: ... http://www.reportlinker.com/p02343464/North-America-Laparoscopes-Market-Outlook-to-2020.html North ... GlobalData,s new report, "North America Laparoscopes Market ... the North America Laparoscopes market. The report provides ...
(Date:8/28/2014)... , Aug. 28, 2014 /PRNewswire-iReach/ -- CountryFocus: ... Poland (Photo - ... CountryFocus: Healthcare, Regulatory and Reimbursement Landscape Poland " ... key trends in the healthcare market and provides ... healthcare infrastructure. Most importantly, the report provides valuable ...
(Date:8/28/2014)... Tianyin Pharmaceutical Co., Inc. (NYSE Amex: ... specializes in patented biopharmaceutical, modernized traditional Chinese medicine ... today updates the timeline for the GMP certification ... The Company is scheduled to submit the ... & Drug Administration,s (CFDA) review in the week ...
Breaking Medicine Technology:North America Laparoscopes Market Outlook to 2020 2North America Laparoscopes Market Outlook to 2020 3North America Laparoscopes Market Outlook to 2020 4North America Laparoscopes Market Outlook to 2020 5North America Laparoscopes Market Outlook to 2020 6North America Laparoscopes Market Outlook to 2020 7North America Laparoscopes Market Outlook to 2020 8North America Laparoscopes Market Outlook to 2020 9North America Laparoscopes Market Outlook to 2020 10North America Laparoscopes Market Outlook to 2020 11Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 2Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 3Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 4Poland & Turkey Pharmaceutical Market worth $15 billion & $21.5 billion Respectively by 2020 5TPI Submits Dataset for GMP Inspection at Qionglai Facility (QLF) 2
... Continues Biocatalysis Business Growth With a Further $4m R&D Investment -- CRAIGAVON, Northern Ireland, October 7, 2010 ... ... if (typeof(lpUnit)==,undefined,) var lpUnit=,PRN,; --> ... = function(data) { var s = ,; var first_result; // Results are keyed by longUrl, so we ...
... N.J., Oct. 7 Novartis Pharmaceuticals Corporation today ... Gilenya™ (fingolimod) 0.5 mg daily, a first-line oral ... was approved by the US Food and Drug ... For people with MS and healthcare professionals seeking ...
Cached Medicine Technology:Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 2Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 3Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 4Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 5Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 6Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 7Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 2Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 3Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 4Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 5Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 6Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 7
(Date:8/29/2014)... "After reading a study that said mortality rates are ... that there needed to be a way to help people ... inventor from Sikestons, Mo. , The Stand provides help for ... and keeps the user from sitting too much. Overall, it's ... in design variations, it's ideal for anyone who wants to ...
(Date:8/29/2014)... August 29, 2014 Ethane Web Technologies, ... launched a new service named HTML web design. , ... service. Before tailoring the service, Ethane Web Technologies did ... companies. The company has done its best efforts to ... able to deliver outstanding results to clients. The ...
(Date:8/29/2014)... of CPR and basic life support (BLS) videos ... with recent health guidelines, according to a new ... the journal for the Australasian College for Emergency ... of sudden cardiac arrest are known to improve ... medicine specialists put together the study, which reviewed ...
(Date:8/29/2014)... across the Arabian Peninsula and spread to Europe several ... of several hundred people since its discovery in 2012. ... how easily the pathogen spreads from human to human. ... the University of Bonn have now come to the ... transmission is low. Still, a third of infected persons ...
(Date:8/29/2014)... Florida (PRWEB) August 29, 2014 The ... pleased to introduce its new Fresh Vegetarian meal plan. ... balanced fresh meals, the new menu is designed to ... their vegetarian lifestyle. , Responding to the ... to be a multi-billion dollar market (Forbes) with 14% ...
Breaking Medicine News(10 mins):Health News:Ethane Web Technologies Launches a New Web Design Service 2Health News:MERS: Low transmissibility, dangerous illness 2Health News:MERS: Low transmissibility, dangerous illness 3Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 2Health News:The Fresh Diet America's #1 At-Home Meal Delivery Company, Debuts Fresh Vegetarian Meal Plan Offering All-Natural Ingredients 3
... American Chemical Society,s (ACS) award-winning " Global Challenges/Chemistry Solutions ... machines seem to be a major source of so-called ... than the head of a pin -- that researchers ... the podcast, Mark Anthony Browne, Ph.D., explains that the ...
... Ill. -- The American Society for Gastrointestinal Endoscopy (ASGE) ... program specifically dedicated to promoting quality in endoscopy, in ... States. The ASGE Endoscopy Unit Recognition Program honors endoscopy ... assurance, endoscope reprocessing and CDC infection control guidelines. To ...
... research hopes to explain premature births and failed inductions of ... Bristol suggests a new mechanism by which the level of ... The researchers, Dr Claire Hudson and Professor Andrs Lpez ... Heesom in the University Proteomics Facility and the School of ...
... Reporter , TUESDAY, Dec. 20 (HealthDay News) -- Sleep problems ... health issues and poorer performance on the job, a new ... from the United States and Canada online or in person ... disorder. The most common problem, suffered by one-third of ...
... use of total hip arthroplasty (THA) and total knee arthroplasty ... postoperative treatment. Aquatic therapy has been shown to have ... after surgery, after the wound has healed. According to ... Medicine and Rehabilitation , beginning aquatic therapy just 6 days ...
... , TUESDAY, Dec. 20 (HealthDay News) -- ... screening to protect all college athletes from sudden death ... a college football player died from complications due to ... mandatory screening of all Division I student athletes. ...
Cached Medicine News:Health News:ASGE recognizes 27 endoscopy units for quality and safety 2Health News:ASGE recognizes 27 endoscopy units for quality and safety 3Health News:Balancing the womb 2Health News:Many Police Officers Battle Sleep Woes, Study Finds 2Health News:Many Police Officers Battle Sleep Woes, Study Finds 3Health News:Aquatic therapy soon after total knee arthroplasty improves outcomes 2Health News:Screening Alone Not Enough to Prevent Sudden Death in College Athletes 2
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... Our breadth of infectious disease ELISA products ... With standard assay protocols for faster integration ... ELISA products provide increased reliability and run-to-run ... antibody detection assays for a wide range ...
... ELISA products make us a leader in ... faster integration into the busy laboratory, our ... and run-to-run consistency. Our Infectious Disease ELISA ... wide range of serological assays including ToRCH, ...
... disease ELISA products make us a leader ... for faster integration into the busy laboratory, ... reliability and run-to-run consistency. Our Infectious Disease ... a wide range of serological assays including ...
Medicine Products: